Home NDC 66983-350 ThyroSafe
Product NDC 66983-350
11-digit product format 669830350
Labeler code 66983
Product ID 66983-350_7a03a65b-330b-4d71-a445-c66eda195a03
Type HUMAN OTC DRUG
Nonproprietary name Potassium Iodide
Dosage form TABLET
Route ORAL
Labeler Recipharm AB (publ)
Application ANDA076350
Marketing category ANDA
Marketing start 2002-09-30
Marketing end 0000-00-00
Substance POTASSIUM IODIDE
Active strength 65 mg/1
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 32 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 66983-350-20 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 66983-350-20 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 66983-350-20 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 66983-350-20 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 66983-350-20 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 66983-350-20 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 66983-350-20 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 66983-350-20 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 66983-350-20 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 66983-350-20 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 66983-350-20 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 66983-350-20 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 66983-350-20 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 66983-350-20 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 66983-350-20 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 66983-350-20 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076350-001 THYROSAFE POTASSIUM IODIDE 65MG TABLET / ORAL RS 2002-09-10 A076350-002 THYROSAFE POTASSIUM IODIDE 130MG TABLET / ORAL 2025-04-02
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 47 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076350-002 THYROSAFE 130MG TABLET / ORAL 2025-04-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076350-002 THYROSAFE 130MG TABLET / ORAL 2025-04-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076350-002 THYROSAFE 130MG TABLET / ORAL 2025-04-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076350-002 THYROSAFE 130MG TABLET / ORAL 2025-04-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A076350-001 THYROSAFE 65MG TABLET / ORAL RS 2002-09-10 053a50430f4f…
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 66983-350-20 ThyroSafe 20 in 1 BOX TABLET 20 3 66983-350-20 ThyroSafe 160 in 1 CARTON TABLET 160 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 66983-350 THYROSAFE (POTASSIUM IODIDE) TABLET [RECIPHARM AB (PUBL)] 3 Legacy NDC, 2 package rows 20211201_4f577f7a-4390-488c-b327-13a32e06be04.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 66983-350-20 66983035020 160 BOX in 1 CARTON (66983-350-20) > 20 BLISTER PACK in 1 BOX > 1 TABLET in 1 BLISTER PACK 160 box 2002-09-30 0000-00-00 No No Current